Bernard A. Fox
@bernardafox.bsky.social
Cancer Immunotherapy & Harder Family Chair Cancer Research #FoxLab @ChilesResearch /CEO @UbiVac / @OHSUmmi.bsky.social /exPres&Ambassador @SITCancer.bsky.social /ex #NCI /ex #Detroit /M GO BLUE/ WIC & JEDI/ @detroitlions.bsky.social /❤️Pinot/Tweets my own
Pinned
Bernard A. Fox
@bernardafox.bsky.social
· Nov 24
Bernard Fox received SITC lifetime achievement award - OncoDaily
Bernard Fox received SITC lifetime achievement award / Bernard Fox, cancer, cancer immunotherapy, Headlines, OncoDaily, Oncology, SITC lifetime achievement
oncodaily.com
Thanks #OncoDaily for the shout out! As noted, no one does this alone. I was incredibly fortunate to have the very best colleagues/friends, students, fellows, supportive philanthropists, & amazing staff at #EACRI & #SITC to work with & together we strove to #FinishCancer.
oncodaily.com/blog/184007
oncodaily.com/blog/184007
Dr. Wim Vos CEO #Radiomics_Bio opens session on Imaging, radionics, and integrated biomarkers at #SITC2025 / important topic that holds promise to predict response and accelerate treatment decisions for patients with cancer #Radiomics
November 8, 2025 at 2:46 PM
Dr. Wim Vos CEO #Radiomics_Bio opens session on Imaging, radionics, and integrated biomarkers at #SITC2025 / important topic that holds promise to predict response and accelerate treatment decisions for patients with cancer #Radiomics
Reposted by Bernard A. Fox
4 decades of IO – Celebrating 40 years of SITC. In 2020, our membership surpassed 4,000 members as we launched two programs: the Certificate in Cancer Immunotherapy and Global Access to Immunotherapy. Our Annual Meeting was held fully virtual due to the COVID-19 pandemic.
November 3, 2025 at 3:02 PM
4 decades of IO – Celebrating 40 years of SITC. In 2020, our membership surpassed 4,000 members as we launched two programs: the Certificate in Cancer Immunotherapy and Global Access to Immunotherapy. Our Annual Meeting was held fully virtual due to the COVID-19 pandemic.
@heinimnatri.bsky.social WELCOME TO #SITC2025 - Hope you find attendance rewarding! @sitcancer.bsky.social
Excited to be attending my first SITC Annual Meeting! On Friday, Brandon Fischer from @nebanovich.bsky.social will present a poster on some of our work on Chlorotoxin CAR T cells. Check it out! #SITC25
November 7, 2025 at 6:21 PM
@heinimnatri.bsky.social WELCOME TO #SITC2025 - Hope you find attendance rewarding! @sitcancer.bsky.social
Reposted by Bernard A. Fox
4 decades of IO – Celebrating 40 years of SITC. In 2024, we published “Challenges and opportunities in cancer immunotherapy: a SITC strategic vision”. We also announced a vision for 100 novel IO agents to be approved by 2034 with IO Drug Development Summit in Boston, MA
November 6, 2025 at 10:00 PM
4 decades of IO – Celebrating 40 years of SITC. In 2024, we published “Challenges and opportunities in cancer immunotherapy: a SITC strategic vision”. We also announced a vision for 100 novel IO agents to be approved by 2034 with IO Drug Development Summit in Boston, MA
Reposted by Bernard A. Fox
Our 2025 Workshop, “Leveraging the Power of Artificial Intelligence to Foster Progress in Immuno-oncology..." educated the IO community to develop new cancer immunotherapies and improve patient care with AI. @jasmineplummer.bsky.social @aruthak.bsky.social @fertiglab.bsky.social @dinler.bsky.social
November 6, 2025 at 10:10 PM
Our 2025 Workshop, “Leveraging the Power of Artificial Intelligence to Foster Progress in Immuno-oncology..." educated the IO community to develop new cancer immunotherapies and improve patient care with AI. @jasmineplummer.bsky.social @aruthak.bsky.social @fertiglab.bsky.social @dinler.bsky.social
Dr Regina Hoo from National Cancer Center Singapore / DukeNUS - tracking adaption and response to therapy in EGFR-mutant #NSCLC. CD39 hi cells & Tregs are enriched in Tx naive pts - TKI Tx reduces exhaustion status/ Tumor-MAC crosstalk/ ALL SLIDES “DO NOT POST” #WIC2025 #SITC2025
November 5, 2025 at 5:30 PM
Dr Beung Chul Ahn @ Center for #LungCancer, #National #Cancer #Institute #Korea / Korean Society for Medical Oncology #KSMO / talks on treatment for lung cancer/ biomarkers to assess patients most likely to benefit from neoadjuvant / adjuvant therapy #WIC2025 #SITC2025
November 5, 2025 at 4:54 PM
Dr Beung Chul Ahn @ Center for #LungCancer, #National #Cancer #Institute #Korea / Korean Society for Medical Oncology #KSMO / talks on treatment for lung cancer/ biomarkers to assess patients most likely to benefit from neoadjuvant / adjuvant therapy #WIC2025 #SITC2025
Dr. Yuan Wang from Univ #Halle & Brandenburg, Germany representing #Tumor #Immunology Meets #Oncology / #TIMO - Talks on class I antigen presentation. Role of miR in regulating tapasin & HLA. Plus TAMs, CXCR3 RBP. #DKFZ #WIC2025 #SITC2025 #Sachsen_Anhalt
November 5, 2025 at 4:43 PM
Dr. Yuan Wang from Univ #Halle & Brandenburg, Germany representing #Tumor #Immunology Meets #Oncology / #TIMO - Talks on class I antigen presentation. Role of miR in regulating tapasin & HLA. Plus TAMs, CXCR3 RBP. #DKFZ #WIC2025 #SITC2025 #Sachsen_Anhalt
Dr. Chen-Yang Huang from Linkou Chang Gang Memorial Hospital, Taiwan representing Taiwan Soc for Immunotherapy of Cancer #TSITC/ Talks on #anticancer effects of #CPG induced neutrophils & clonal expansion of T cells/. #WIC2025 #SITC2025
November 5, 2025 at 4:13 PM
Dr. Chen-Yang Huang from Linkou Chang Gang Memorial Hospital, Taiwan representing Taiwan Soc for Immunotherapy of Cancer #TSITC/ Talks on #anticancer effects of #CPG induced neutrophils & clonal expansion of T cells/. #WIC2025 #SITC2025
Dr Loubna Oumeslakht representing the #Moracan Society for #Immunology talked on #Sezary #Syndrome Cells/ kinetics of #ICOSligands & role of ICOS isoforms in disease and as a target for treatment. #WIC2025 #SITC2025
November 5, 2025 at 3:54 PM
Dr Loubna Oumeslakht representing the #Moracan Society for #Immunology talked on #Sezary #Syndrome Cells/ kinetics of #ICOSligands & role of ICOS isoforms in disease and as a target for treatment. #WIC2025 #SITC2025
Catherine Phelps from @upmc.com representing #SITC Talks on how #exercise can improve outcome - role for #microbial #metabolite #formate on mediating #anticancer #immunity / #WIC2025 #SITC2025
November 5, 2025 at 3:22 PM
Catherine Phelps from @upmc.com representing #SITC Talks on how #exercise can improve outcome - role for #microbial #metabolite #formate on mediating #anticancer #immunity / #WIC2025 #SITC2025
Dr Pan Jia Wern representing #Malaysian Soc for #Biochemistry & #Molecular #Biology talks on #BreastCancer / role of parity, microbiome, & germline variants/ #APOBEC3B deletion has increased RR to anti-PD-1 #WIC2025 #SITC2025
November 5, 2025 at 2:21 PM
Dr Pan Jia Wern representing #Malaysian Soc for #Biochemistry & #Molecular #Biology talks on #BreastCancer / role of parity, microbiome, & germline variants/ #APOBEC3B deletion has increased RR to anti-PD-1 #WIC2025 #SITC2025
Dr. Augusto Bleve representing #Italian #Network for #Tumor #Biotherapy ( #NIBIT ) talks on role of #hypercholesterolemia on #anticancer #immunity / #PCSK9 #RORgamma #WIC2025 #SITC2025
November 5, 2025 at 1:54 PM
Dr. Augusto Bleve representing #Italian #Network for #Tumor #Biotherapy ( #NIBIT ) talks on role of #hypercholesterolemia on #anticancer #immunity / #PCSK9 #RORgamma #WIC2025 #SITC2025
Dr. Joao Scarini from #Brazil & representing #Latin #American & #Caribbean #Association For #Immunology evaluated differences between pts that recur & those that are disease free. TCR diversity - See conclusions. #WIC2025 #SITC2025
November 5, 2025 at 1:41 PM
Dr. Joao Scarini from #Brazil & representing #Latin #American & #Caribbean #Association For #Immunology evaluated differences between pts that recur & those that are disease free. TCR diversity - See conclusions. #WIC2025 #SITC2025
Michael Geuenich PhD student representative from #Canadian #Cancer #Immunotherapy #Consortium (CCIC) talks on AI and Tertiary lymphoid structuctures in #pancreatic cancer. #SITC2025 #WIC2025
November 5, 2025 at 1:25 PM
Michael Geuenich PhD student representative from #Canadian #Cancer #Immunotherapy #Consortium (CCIC) talks on AI and Tertiary lymphoid structuctures in #pancreatic cancer. #SITC2025 #WIC2025